Difficulties in treating steroid withdrawal: intermittent ACTH and low dose systemic cyclosporin used to treat a senile erythroderma patient.
The tapering or termination of prolonged strong topical and/or systemic corticosteroid application for extensive generalized eczema has adverse effects on the body and thus presents a very difficult situation. The present case is that of a 68-year-old man with erythroderma following eczema, whose steroid withdrawal was successfully treated with intermittent ACTH and low dose systemic cyclosporin administration over a period of one year.
Horiuchi
Y
Y
Division of Dermatology, Tsukuba Memorial Hospital, Japan.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D000368:Aged; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced / Q000188:drug therapy*; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D008297:Male; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy* / Q000209:etiology
D005938:Glucocorticoids; D016572:Cyclosporine; D000324:Adrenocorticotropic Hormone